Hormone important for menstrual cycle and pregnancy
13 of 22 providers
Sex Hormones (Female)
Follicular:<1.0 ng/mL, Luteal:2.0-25.0 ng/mL, Postmenopausal:<1.0 ng/mL
Progesterone is a steroid hormone produced primarily by the corpus luteum in the ovaries after ovulation in women, and in smaller amounts by the adrenal glands in both sexes and the testes in men. In women, progesterone is THE dominant hormone of the luteal phase (second half of menstrual cycle, days 15-28) and is essential for preparing the uterus for pregnancy, regulating the menstrual cycle, supporting pregnancy, and balancing the effects of estrogen. Progesterone has calming, anti-anxiety effects on the brain and is critical for sleep quality.
Here's what most people misunderstand:progesterone is not just a "pregnancy hormone."It's protective against estrogen dominance, supports mood and sleep, has neuroprotective effects, and is critical for bone health and breast tissue protection. Low progesterone in premenopausal women is common and often causes PMS, irregular cycles, anxiety, insomnia, and increased risk of estrogen-dependent cancers. In menopause, both estrogen AND progesterone decline, but replacing estrogen without progesterone (if uterus is intact) increases endometrial cancer risk.
Progesterone levels vary dramatically across the menstrual cycle. It's very low in the follicular phase (<1 ng/mL), then spikes after ovulation to 5-25 ng/mL in the luteal phase. Testing progesterone on day 21 of a 28-day cycle (or 7 days after ovulation) confirms ovulation occurred. Low progesterone despite normal estrogen=anovulation or luteal phase deficiency, common causes of infertility and menstrual irregularity.
| Range Type | Level | Significance |
|---|---|---|
| Optimal (Luteal Phase) | 10-25 ng/mL | Mid-luteal phase (day 21 of 28-day cycle). Confirms ovulation occurred and adequate progesterone production. |
| Optimal (Follicular Phase) | <1 ng/mL | Progesterone should be very low before ovulation. Elevated progesterone in follicular phase may indicate luteinized unruptured follicle or adrenal issue. |
| Optimal (Pregnancy - First Trimester) | 10-90 ng/mL | Progesterone rises dramatically in pregnancy, produced by corpus luteum then placenta. |
| Optimal (Postmenopausal on HRT) | 1-5 ng/mL | Bioidentical progesterone HRT (oral or topical) maintains levels to protect endometrium if taking estrogen. |
<5 ng/mL
Very Low (Postmenopausal without HRT)
Expected after menopause. Adrenal glands produce small amounts. If on estrogen HRT, must add progesterone to protect uterus.
Oral micronized progesterone (Prometrium):100-200 mg at bedtime. Bioidentical, identical to human progesterone. Has calming, sleep-promoting effects. Used for luteal phase support, HRT, or PMS.
Progesterone cream:Topical application (20-40 mg/day) absorbed through skin. Useful for perimenopause or mild progesterone deficiency. Variable absorption.
Progesterone suppositories:Vaginal or rectal. Used for luteal phase support in fertility treatment or early pregnancy.
Avoid synthetic progestins:Medroxyprogesterone acetate (Provera) and other synthetic progestins have different effects than bioidentical progesterone and may increase breast cancer risk and harm lipid profile.
Most common cause of low progesterone is anovulation (no ovulation=no corpus luteum=no progesterone).
Address underlying causes:PCOS (insulin resistance drives anovulation), hypothalamic amenorrhea (low body weight, excessive exercise, chronic stress), thyroid dysfunction, hyperprolactinemia.
Lifestyle:Maintain healthy body weight (BMI 18-25), reduce stress, adequate calorie intake (not chronic dieting), resistance training.
Vitex (chasteberry):20-40 mg/day may support ovulation and luteal phase progesterone in some women. Modest evidence.
Ovulation induction:Clomiphene or letrozole if trying to conceive and anovulatory despite lifestyle changes.
Sedation, drowsiness (if very high dose)|Dizziness|Bloating|Breast tenderness|Mood changes (rare with bioidentical;more common with synthetic progestins)
Source:Progesterone rarely causes problems even at high doses. High progesterone (>30 ng/mL in non-pregnant women) may indicate ovarian cyst or adrenal tumor (very rare).
Ovarian cyst (corpus luteum cyst):Persistent corpus luteum continues producing progesterone after cycle.|Adrenal tumor (very rare):Adrenal glands produce small amounts of progesterone;tumors can overproduce.|Pregnancy:Progesterone rises dramatically to support pregnancy.|Congenital adrenal hyperplasia:Rare enzyme deficiency causes overproduction of progesterone precursors.
Source:If trying to conceive:Test progesterone on day 21 of 28-day cycle (or 7 days post-ovulation if tracking ovulation). Should be >10 ng/mL to confirm ovulation and adequate luteal phase.|If starting progesterone supplementation:Retest mid-luteal phase after 2-3 months to ensure adequate replacement.|If on HRT:Monitor progesterone levels if using cream (variable absorption). Oral progesterone dosing doesn't require monitoring if symptoms controlled and withdrawal bleed occurs (if cyclic HRT).|If treating infertility:Serial progesterone testing in luteal phase to confirm ovulation and adequate support.|If perimenopausal with irregular cycles:Test progesterone day 21 (if still cycling) to assess ovulatory status and guide treatment.
Progesterone opposes estrogen's proliferative effects on breast and uterine tissue. "Estrogen dominance"(high estrogen relative to progesterone) increases risk of breast cancer, endometrial hyperplasia, fibroids, and endometriosis. This is common in perimenopause (progesterone declines before estrogen) and anovulatory women.
Source:Prior JC. Progesterone for symptomatic perimenopause treatment. Menopause. 2018;25(12):1453-1455.
Progesterone metabolite allopregnanolone acts on GABA-A receptors (like benzodiazepines), promoting sleep and reducing anxiety. Women with low progesterone often report insomnia, especially premenstrually. Oral micronized progesterone 100-200 mg at bedtime improves sleep quality.
Source:Caufriez A, et al. Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion. J Clin Endocrinol Metab. 2011;96(4):E614-623.
Bioidentical progesterone (Prometrium, compounded) is chemically identical to human progesterone. Synthetic progestins (medroxyprogesterone acetate/Provera, norethindrone) have different structure and effects:they may increase breast cancer risk, negatively affect lipid profile, and have more side effects. Bioidentical progesterone preferred for HRT.
Source:Asi N, et al. Progesterone vs. synthetic progestins and the risk of breast cancer. Syst Rev. 2016.
| Provider | Includes | Annual Cost | Biomarkers |
|---|---|---|---|
| ✓ | $199 | 100+ (150 with ratios) | |
| — | $349 | 65 | |
| — | $398 | 30+ | |
| ✓ | $486 | 40+ | |
| ✓ | $468 | 83 | |
| ✓ | $349 | 100+ | |
| ✓ | $680 | 54 | |
| ✓ | $365 | 100+ | |
| — | $250 | 65 | |
| ✓ | $495 | 70+ | |
| ✓ | $895 | 100+ | |
| ✓ | $1950 | 150+ | |
| — | $399 | 100+ | |
| — | $Varies | 75+ | |
| — | $190 | 100+ | |
| — | $99 | 50 | |
| ✓ | $125 | 60 | |
| — | $199 | 50 | |
| ✓ | $499 | 120+ | |
| ✓ | $4188 | 80+ | |
| — | $375 | 85 | |
| — | $700 | 129 |
13 providers include this biomarker in their panels
This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider about your specific health needs.